These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 38838634)

  • 1. Exploring Dimethylsulfoniopropionate as a potential treatment for Alzheimer's disease: A study using the 3 × Tg-AD mouse model.
    Sun F; Huang X; Wang H; Lin B; Li H; Wang X; Liu Q
    Phytomedicine; 2024 Jul; 130():155788. PubMed ID: 38838634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein III Decreases the Proliferation of Astrocytes and Enhances Pathological Improvements in a Mouse Model of Alzheimer's Disease.
    Lv J; Wang F; Wang T; Shi Y
    Discov Med; 2024 Jun; 36(185):1221-1230. PubMed ID: 38926108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.
    Zheng M; Liu Z; Mana L; Qin G; Huang S; Gong Z; Tian M; He Y; Wang P
    J Ethnopharmacol; 2021 Oct; 278():114264. PubMed ID: 34082015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icariin Ameliorates Alzheimer's Disease Pathology by Alleviating Myelin Injury in 3 × Tg-AD Mice.
    Yu H; Shi J; Lin Y; Zhang Y; Luo Q; Huang S; Wang S; Wei J; Huang J; Li C; Ji L
    Neurochem Res; 2022 Apr; 47(4):1049-1059. PubMed ID: 35037164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
    He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
    Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer's Disease.
    Maiti P; Manna J; Burch ZN; Flaherty DB; Larkin JD; Dunbar GL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
    Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
    Cells; 2021 May; 10(5):. PubMed ID: 34064687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages.
    Vandini E; Ottani A; Zaffe D; Calevro A; Canalini F; Cavallini GM; Rossi R; Guarini S; Giuliani D
    Pharmacology; 2019; 103(1-2):50-60. PubMed ID: 30448835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric Acid Mitigates Cognitive Deficits via TFEB-Mediated Microglial Autophagy in Mice Models of Alzheimer's Disease.
    Xiao Q; Wang J; Tian Q; Tian N; Tian Q; He X; Wang Y; Dong Z
    Mol Neurobiol; 2024 Jun; 61(6):3678-3696. PubMed ID: 38008888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX; Zhao RP; Wang DS; Wang AN
    Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of the traditional decoction Tian-Si-Yin against Alzheimer's disease via suppression of neuroinflammation.
    Zhou L; Yang C; Liu Z; Chen L; Wang P; Zhou Y; Yuan M; Zhou LT; Wang X; Zhu LQ
    J Ethnopharmacol; 2024 Mar; 321():117569. PubMed ID: 38086513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.